Zimmer Biomet Holdings (ZBH) Invested Capital (2009 - 2026)

Zimmer Biomet Holdings has reported Invested Capital for 18 years, with the latest figure at $13.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 2.26% year-over-year to $13.6 billion; the trailing twelve-month figure through Mar 2026 stood at $13.6 billion (up 2.26% YoY), and the FY2025 full-year result was $13.6 billion, up 4.59% from the prior year.
• Invested Capital for Q1 2026 stood at $13.6 billion, roughly flat from $13.6 billion in the prior quarter.
• The five-year high for Invested Capital was $18.1 billion in Q3 2022, with the low at $12.7 billion in Q4 2023.
• Average Invested Capital over 5 years is $14.7 billion, with a median of $13.6 billion recorded in 2026.
• Year-over-year, Invested Capital jumped 32.7% in 2022 and fell 26.2% in 2023.
• Tracing ZBH's Invested Capital over 5 years: stood at $12.9 billion in 2022, then decreased by 1.12% to $12.7 billion in 2023, then rose by 1.95% to $13.0 billion in 2024, then advanced by 4.59% to $13.6 billion in 2025, then retreated by 0.19% to $13.6 billion in 2026.
• The last three Invested Capital figures came in at $13.6 billion (Q1 2026), $13.6 billion (Q4 2025), and $13.6 billion (Q3 2025), per Business Quant data.

Peer Comparison